Wikipedia:Articles for deletion/Nabi Biopharmaceuticals


 * The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review).  No further edits should be made to this page.

The result was soft delete. WP:REFUND applies.  So Why  15:05, 15 August 2017 (UTC)

Nabi Biopharmaceuticals

 * – ( View AfD View log  Stats )

Does not meet WP:CORPDEPTH or WP:GNG. Available news sources in various internet searches are largely promotional press releases, routine coverage and passing mentions, and book sources are only providing passing mentions and directory listings. North America1000 02:14, 7 August 2017 (UTC)
 * Note: This debate has been included in the list of Companies-related deletion discussions. North America1000 02:16, 7 August 2017 (UTC)
 * Note: This debate has been included in the list of Medicine-related deletion discussions. North America1000 02:17, 7 August 2017 (UTC)
 * Note: This debate has been included in the list of Maryland-related deletion discussions. North America1000 02:17, 7 August 2017 (UTC)


 * Delete No substantial claims of notability -- only apparent product failed during drug trials. Company no longer exists under this name.  caknuck °  needs to be running more often  21:33, 7 August 2017 (UTC)


 * The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.